Moody's lowers its rating on Dentsply (XRAY) to Baa2, maintaining a stable outlook on the maker...


Moody's lowers its rating on Dentsply (XRAY) to Baa2, maintaining a stable outlook on the maker of dental devices. The ratings agency took note of the extra debt the firm is picking up as part of the $1.8B deal to acquire AstraZeneca's (AZN) dental impant business.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs